Follow
Ching-Ni Njauw
Ching-Ni Njauw
Massachussetts General Hospital
Verified email at partners.org
Title
Cited by
Cited by
Year
Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function
A Boni, AP Cogdill, P Dang, D Udayakumar, CNJ Njauw, CM Sloss, ...
Cancer research 70 (13), 5213-5219, 2010
7952010
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling
U McDermott, SV Sharma, L Dowell, P Greninger, C Montagut, J Lamb, ...
Proceedings of the National Academy of Sciences 104 (50), 19936-19941, 2007
4032007
Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families
CNJ Njauw, I Kim, A Piris, M Gabree, M Taylor, AM Lane, MM DeAngelis, ...
PloS one 7 (4), e35295, 2012
2692012
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide
S Walpole, AL Pritchard, CM Cebulla, R Pilarski, M Stautberg, ...
JNCI: Journal of the National Cancer Institute 110 (12), 1328-1341, 2018
2032018
Differentiation syndrome associated with enasidenib, a selective inhibitor of mutant isocitrate dehydrogenase 2: analysis of a phase 1/2 study
AT Fathi, CD DiNardo, I Kline, L Kenvin, I Gupta, EC Attar, EM Stein, ...
JAMA oncology 4 (8), 1106-1110, 2018
1832018
Genotypic and phenotypic features of BAP1 cancer syndrome: a report of 8 new families and review of cases in the literature
AM Haugh, CN Njauw, JA Bubley, AE Verzě, B Zhang, E Kudalkar, ...
JAMA dermatology 153 (10), 999-1006, 2017
1062017
EphA2 is a critical oncogene in melanoma
D Udayakumar, G Zhang, Z Ji, CN Njauw, P Mroz, H Tsao
Oncogene 30 (50), 4921-4929, 2011
992011
p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition
Z Ji, CN Njauw, M Taylor, V Neel, KT Flaherty, H Tsao
Journal of investigative dermatology 132 (2), 356-364, 2012
932012
MITF modulates therapeutic resistance through EGFR signaling
Z Ji, YE Chen, R Kumar, M Taylor, CNJ Njauw, B Miao, DT Frederick, ...
Journal of Investigative Dermatology 135 (7), 1863-1872, 2015
892015
EphA2 Is an Essential Mediator of UV Radiation–Induced Apoptosis
G Zhang, CN Njauw, JM Park, C Naruse, M Asano, H Tsao
Cancer research 68 (6), 1691-1696, 2008
632008
High MITF expression is associated with super-enhancers and suppressed by CDK7 inhibition in melanoma
P Eliades, BJ Abraham, Z Ji, DM Miller, CL Christensen, N Kwiatkowski, ...
Journal of Investigative Dermatology 138 (7), 1582-1590, 2018
552018
Cloning and characterization of the pheromone biosynthesis activating neuropeptide receptor gene in Spodoptera littoralis larvae
L Zheng, C Lytle, C Njauw, M Altstein, M Martins-Green
Gene 393 (1-2), 20-30, 2007
532007
Hypoxia and HIF-1α regulate collagen production in keloids
Y Kang, MR Roh, S Rajadurai, A Rajadurai, R Kumar, CN Njauw, Z Zheng, ...
Journal of Investigative Dermatology 140 (11), 2157-2165, 2020
512020
Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma
V Nikolaou, X Kang, A Stratigos, H Gogas, MC Latorre, M Gabree, ...
British Journal of Dermatology 165 (6), 1219-1222, 2011
512011
Vemurafenib synergizes with nutlin-3 to deplete survivin and suppresses melanoma viability and tumor growth
Z Ji, R Kumar, M Taylor, A Rajadurai, A Marzuka-Alcalá, YE Chen, ...
Clinical Cancer Research 19 (16), 4383-4391, 2013
482013
Rare variant, gene-based association study of hereditary melanoma using whole-exome sequencing
M Artomov, AJ Stratigos, I Kim, R Kumar, M Lauss, BY Reddy, B Miao, ...
JNCI: Journal of the National Cancer Institute 109 (12), djx083, 2017
302017
Use of targeted next-generation sequencing to identify activating hot spot mutations in cherry angiomas
N Klebanov, WM Lin, M Artomov, M Shaughnessy, CN Njauw, R Bloom, ...
JAMA dermatology 155 (2), 211-215, 2019
292019
Multiple cutaneous melanomas and clinically atypical moles in a patient with a novel germline BAP1 mutation
P Gerami, O Yélamos, CY Lee, R Obregon, P Yazdan, LM Sholl, ...
JAMA dermatology 151 (11), 1235-1239, 2015
252015
Growth suppression by dual BRAF (V600E) and NRAS (Q61) oncogene expression is mediated by SPRY4 in melanoma
R Kumar, CN Njauw, BY Reddy, Z Ji, A Rajadurai, N Klebanov, H Tsao
Oncogene 38 (18), 3504-3520, 2019
202019
Cancer risks associated with the germline MITF (E318K) variant
SM Guhan, M Artomov, S McCormick, CN Njauw, AJ Stratigos, K Shannon, ...
Scientific Reports 10 (1), 17051, 2020
192020
The system can't perform the operation now. Try again later.
Articles 1–20